| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Director | Common Stock | 87,943 | $2,555,624 | $29.06 | 23 Feb 2024 | Direct |
| SUPERNUS PHARMACEUTICALS, INC. | Director | Restricted Stock Unit | 0 | $0 | $29.06 | 23 Feb 2024 | Direct |
| SUPERNUS PHARMACEUTICALS, INC. | Director | Director Stock Option (Right to Buy) | 8,252 | 22 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | 23 Feb 2024 | 2 | $0 | 4 | Director | 27 Feb 2024, 17:02 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | 22 Feb 2024 | 2 | $0 | 4 | Director | 26 Feb 2024, 17:01 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | 23 Feb 2023 | 2 | $0 | 4 | Director | 27 Feb 2023, 16:01 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | 22 Feb 2023 | 2 | $0 | 4 | Director | 24 Feb 2023, 16:16 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | 22 Feb 2022 | 2 | $0 | 4 | Director | 24 Feb 2022, 20:26 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | 19 Feb 2022 | 2 | $0 | 4 | Director | 23 Feb 2022, 15:15 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | 11 Aug 2021 | 2 | +$194,700 | 4 | Director | 12 Aug 2021, 16:32 |